Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125811 · ClinicalTrials.gov registry record · Early Phase 1
Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)
A Early Phase 1 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 121
- Enrollment target
NCT03125811 is a Early Phase 1 study that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 121 participants.
The verdict
NCT03125811, a Early Phase 1 study, has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 121 participants
- Enrollment target
Study Summary
This study will compare two different ways to relieve nausea and vomiting in the Emergency Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.
Interventions
- OTHER Inhaled Isopropyl Alcohol (IPA)
- DRUG Oral Dissolvable Tablet Zofran (ondansetron)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2023-03-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03125811
The ClinicalTrials.gov registry entry for NCT03125811 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Inhaled Isopropyl Alcohol (IPA) is the first listed.
NCT03125811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03125811 about?
NCT03125811 is a clinical study titled "Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)". This study will compare two different ways to relieve nausea and vomiting in the Emergency Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.
What is the current status of trial NCT03125811?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 121 participants. The study started on 2017-07-17. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT03125811?
The interventions under investigation include: Inhaled Isopropyl Alcohol (IPA) (OTHER), Oral Dissolvable Tablet Zofran (ondansetron) (DRUG).
Who is sponsoring clinical trial NCT03125811?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.